TI
MEDP icon

Trexquant Investment’s Medpace MEDP Stock Holding History

Trexquant Investment’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.57M Sell
6,742
-21,774
-76% -$10M 0.02% 919
2026
Q1 		$13.7M Buy
28,516
+398
+1% +$204K 0.1% 269
2025
Q4 		$15.8M Buy
28,118
+11,563
+70% +$6.56M 0.14% 180
2025
Q3 		$8.51M Sell
16,555
-16,322
-50% -$7.13M 0.09% 353
2025
Q2 		$10.3M Sell
32,877
-36,304
-52% -$10.9M 0.12% 238
2025
Q1 		$21.1M Buy
69,181
+33,680
+95% +$11.3M 0.25% 81
2024
Q4 		$11.8M Buy
35,501
+20,103
+131% +$6.82M 0.14% 219
2024
Q3 		$5.14M Buy
15,398
+11,915
+342% +$4.53M 0.07% 461
2024
Q2 		$1.43M Sell
3,483
-5,991
-63% -$2.37M 0.02% 872
2024
Q1 		$3.83M Buy
9,474
+5,191
+121% +$1.83M 0.08% 403
2023
Q4 		$1.31M Sell
4,283
-2,127
-33% -$574K 0.03% 720
2023
Q3 		$1.55M Buy
6,410
+4,737
+283% +$1.21M 0.04% 573
2023
Q2 		$402K Sell
1,673
-15,147
-90% -$3.15M 0.01% 1087
2023
Q1 		$3.16M Sell
16,820
-341
-2% -$70.5K 0.09% 308
2022
Q4 		$3.65M Buy
+17,161
New +$3.43M 0.1% 267
2022
Q3 		– Sell
-3,874
Closed -$580K – 1663
2022
Q2 		$580K Sell
3,874
-4,643
-55% -$672K 0.03% 743
2022
Q1 		$1.39M Buy
8,517
+6,729
+376% +$1.11M 0.07% 366
2021
Q4 		$389K Buy
+1,788
New +$374K 0.02% 785
2021
Q2 		– Sell
-2,003
Closed -$329K – 1330
2021
Q1 		$329K Buy
+2,003
New +$306K 0.03% 700
2020
Q2 		– Sell
-3,669
Closed -$269K – 1341
2020
Q1 		$269K Buy
+3,669
New +$319K 0.02% 890
2019
Q4 		– Sell
-6,793
Closed -$571K – 1180
2019
Q3 		$571K Buy
+6,793
New +$513K 0.05% 422
2018
Q3 		– Sell
-6,895
Closed -$296K – 1097
2018
Q2 		$296K Buy
+6,895
New +$279K 0.02% 684
2017
Q2 		– Sell
-17,300
Closed -$516K – 1014
2017
Q1 		$516K Buy
+17,300
New +$558K 0.07% 522

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Trexquant Investment's MEDP Position: Q2 2026 in Review

Trexquant Investment reduced its Medpace (MEDP) stake by 76% in Q2 2026, selling an estimated $10M and leaving 6,742 shares worth $3.57M. The position accounts for 0.02% of the portfolio, ranked #919.

Trexquant Investment first reported a position in MEDP in Q1 2017 and has held it in 23 quarters since. The position peaked at $21.1M in Q1 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Trexquant Investment held 6,742 shares of Medpace worth $3.57M as of Q2 2026.
  • Trexquant Investment sold 21,774 Medpace shares in Q2 2026, an estimated $10M.
  • Medpace made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #919 holding.
  • Trexquant Investment first reported a position in Medpace in Q1 2017 and has held it in 23 quarters since.
  • Trexquant Investment's Medpace position peaked at $21.1M in Q1 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.